The Cholinergic Systems of the Eye

  • T. W. Mittag
Part of the Advances in Behavioral Biology book series (ABBI, volume 25)


Tissues of the eye possess several interesting features which make them particularly useful for certain types of experimental studies on transmitter systems. For example, ocular structures can be readily denervated or given chronic drug treatments with little trauma or systemic drug effect to the experimental animal. Some of these advantages are illustrated by studies discussed here on acetylcholine (ACh) and the cholinergic system present in cornea, and studies on the dynamics of ACh receptors in the intraocular smooth muscle of iris and ciliary body.


Cholinergic System Ciliary Body Rabbit Cornea Ocular Structure Choline Acetyl Transferase 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Barker, L.A. and Mittag, T.W. (1973): FEBS Lett. 35:141–144.CrossRefGoogle Scholar
  2. 2.
    Barker, L.A. and Mittag, T.W. (1975): J. Pharmacol. Exp. Ther. 192:86–94.Google Scholar
  3. 3.
    Bito, L.Z., Hyslop, K. and Hyndman, J. (1967): J. Pharmacol. Exp. Ther. 157:159–169.Google Scholar
  4. 4.
    Boberg-Ans, J. (1955): Brit. J. Opthal. 39: 705–726.CrossRefGoogle Scholar
  5. 5.
    Bolt, Beranek & Newman, InG. (1979): Public Procedures Note book: A Program Exchange for PROPHET Users. The Chem. Biol. Info. Handling Prog. NIH.Google Scholar
  6. 6.
    Brücke, H. von (1938): Klin. Wochenschrift. 17:420–422.CrossRefGoogle Scholar
  7. 7.
    Brücke, H. von, Hellauer, H.F. and Umrath, K. (1949): Qphthal-mologia 117:19–35.Google Scholar
  8. 8.
    Gnadinger, M.C., Heiman, R. and Markstein, R. (1973): Exp. Eye Res. 15:395–399.CrossRefGoogle Scholar
  9. 9.
    Harris, L.S., Mittag, T.W., Denmark, L.W., Cohn, K. and Galin, M.A. (1972): Exp. Eye Res. 13:1–8.CrossRefGoogle Scholar
  10. 10.
    Harris, L.S., Shimmyo, M. and Mittag, T.W. (1973): Arch. Ophthalmol. 89:49–51.CrossRefGoogle Scholar
  11. 11.
    Korczyn, A.D., Kloog, Y., Heron, D.S., Sachs, D.I. and Sokolovsky, M. (1979): Invest. Ophthal. Vis. Sci. 18: Suppl. 189.Google Scholar
  12. 12.
    Kornblueth, W. (1949): Amer. J. Opthalmol. 32:781–790.Google Scholar
  13. 13.
    Masland, R.H. and Livingstone, C.J. (1976): J. Neuro Physiol. 39:1210–1219.Google Scholar
  14. 14.
    Mindel, J.S. and Mittag, T.W. (1976): Invest. Ophthalmol. 15:808–814.Google Scholar
  15. 15.
    Mindel, J.S. and Mittag, T.W. (1977): Exp. Eye Res. 24:25–33.CrossRefGoogle Scholar
  16. 16.
    Minde 1, J.S. and Mittag, T.W. (1978): Exp. Eye Res. 27:359–364.CrossRefGoogle Scholar
  17. 17.
    Mittag, T.W. (1979): Invest. Ophthal. Vis. Sci. 18: Suppl. 189.Google Scholar
  18. 18.
    Mittag, T.W., Ehrenpreis, S. and Hehir, R.M. (1971): Biochem. Pharmacol. 20:2263–2273.CrossRefGoogle Scholar
  19. 19.
    Mittag, T.W., Ehrenpreis, S. and Patrick, P. (1971): Arch. Int. Pharmacodyn. Ther. 191:270–278.Google Scholar
  20. 20.
    Mittag, T.W., Tormay, A. and Massa, T. (1978): Mol. Pharmacol. 14:60–68.Google Scholar
  21. 21.
    Williams, J.D. and Cooper, J.R. (1965): Biochem. Pharmacol. 14:1286–1289.CrossRefGoogle Scholar
  22. 22.
    Yamamura, H.I. and Snyder, S.H. (1974): Mol. Pharmacol. 10: 861–868.Google Scholar
  23. 23.
    Zander, E. and Weddell, G. (1951): J. Anat. 85:68–99.Google Scholar

Copyright information

© Plenum Press, New York 1981

Authors and Affiliations

  • T. W. Mittag
    • 1
  1. 1.Department of PharmacologyMount Sinai School of Medicine CUNYNew YorkUSA

Personalised recommendations